These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6692721)

  • 1. Effects of three new folate antagonists on human breast adenocarcinoma cells in vitro and on immune responses in vivo.
    Tsang KY; Hynes JB; Fudenberg HH; Pan JF
    Chemotherapy; 1984; 30(1):61-8. PubMed ID: 6692721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 5,8-dideazaisofolic acid (IAHQ) on human tumor cells in culture and on normal and tumor-bearing hamsters.
    Tsang KY; Hynes JB; Fudenberg HH
    Chemotherapy; 1982; 28(4):276-82. PubMed ID: 6956488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved synthesis and antitumor evaluation of 5,8-dideazaisofolic acid and closely related analogues.
    Hynes JB; Yang YC; McGill JE; Harmon SJ; Washtien WL
    J Med Chem; 1984 Feb; 27(2):232-5. PubMed ID: 6694171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
    Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.
    Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G
    Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate.
    Takemura Y; Ohnuma T
    Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of X-methyl folate preparations as possible folic acid antagonists.
    Waxman S; Schreiber C; Waxman S
    Chemotherapy; 1982; 28(5):402-9. PubMed ID: 7140422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors.
    Jansen G; Schornagel JH; Westerhof GR; Rijksen G; Newell DR; Jackman AL
    Cancer Res; 1990 Dec; 50(23):7544-8. PubMed ID: 2253202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monitoring the immune status of breast cancer patients under adjuvant chemotherapy and polychemotherapy].
    Kreienberg R; Melchert F; Lemmel EM
    Onkologie; 1979 Oct; 2(5):181-6. PubMed ID: 395473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of the therapeutic activity of lometrexol -(6-R)5,10-dideazatetrahydrofolate- by oral folic acid.
    Alati T; Worzalla JF; Shih C; Bewley JR; Lewis S; Moran RG; Grindey GB
    Cancer Res; 1996 May; 56(10):2331-5. PubMed ID: 8625328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-arginine stimulates host defenses in patients with breast cancer.
    Brittenden J; Park KG; Heys SD; Ross C; Ashby J; Ah-See Ak; Eremin O
    Surgery; 1994 Feb; 115(2):205-12. PubMed ID: 8310409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.
    Muraro E; Comaro E; Talamini R; Turchet E; Miolo G; Scalone S; Militello L; Lombardi D; Spazzapan S; Perin T; Massarut S; Crivellari D; Dolcetti R; Martorelli D
    J Transl Med; 2015 Jun; 13():204. PubMed ID: 26116238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
    Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
    Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic activity of fusaric acid on human adenocarcinoma cells in tissue culture.
    Fernandez-Pol JA; Klos DJ; Hamilton PD
    Anticancer Res; 1993; 13(1):57-64. PubMed ID: 8476229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative evaluation of the lymphocyte blast-transformation reaction induced by various mitogens in the polychemotherapy of patients with breast cancer].
    Gnatyshak AI; Sabala PI
    Eksp Onkol; 1984; 6(1):61-3. PubMed ID: 6499735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.
    Okamoto M; Ohe G; Furuichi S; Nishikawa H; Oshikawa T; Tano T; Ahmed SU; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
    Anticancer Res; 2002; 22(6A):3229-39. PubMed ID: 12530069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.